Finance Watch: Royalty Deals Pick Up As Alternative Financings Find Appeal

Pfizer Prices $31bn Debt Offering To Fund Seagen Buy

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.